HHH
Howard Hughes Holdings Inc.
$66.70
-2.90% 2026-10-19
Real Estate
HHHSPY
1W
-7.8%
1M
+10.8%
3M
-2.6%
6M
-1.1%
YTD
-16.4%
1Y
-16.4%
Grades vs sector
Momentumno data–
Momentum
no data
Percentile within its GICS sector across the S&P 1500.
Growthno data–
Growth
no data
Percentile within its GICS sector across the S&P 1500.
Valueno data–
Value
no data
Percentile within its GICS sector across the S&P 1500.
Profitabilityno data–
Profitability
no data
Percentile within its GICS sector across the S&P 1500.
Revisionsno data–
Revisions
no data
30-day change in analysts' current-year EPS estimate; graded across covered stocks.
Our models
Not held by any of our 3 live models right now.
Momentum Top 15
not ranked (outside this model's universe or screens)
Quality Growthnot ranked (outside this model's universe or screens)
Momentum Blendnot in the current book
Key stats
Market cap$4.0B
P/E (trailing)13.5
P/E (forward)19.4
52-week range60.09 – 91.07
Revenue growth (YoY, latest qtr)+330.2%
Dividend yield0.00%
Analyst consensusBuy (3)
Mean price target$84.00 (+26%)
Valuation & fundamentals
Bottom line
Leans undervalued
Model read-out from the numbers below, not advice. Score +2 (DCF counts double).
▲DCF (base case)above the price by 1013%
•Piotroski F-score4/9
▼Altman Z0.5 (distress)
•Net debt / EBITDA3.5x
▲Analyst target+26% (3 analysts)
Discounted cash flow
Bear
$310
+364%
growth 18% · disc. 10.9% · term. 2.0%
Base
$743
+1013%
growth 30% · disc. 9.9% · term. 2.5%
Bull
$1,412
+2017%
growth 38% · disc. 8.9% · term. 3.0%
A DCF starts from trailing free cash flow, so it can overstate value if the last 12 months were unusually strong (or weak). Use the bear case or edit the starting cash flow if so.
Reverse DCFfor context, not a signal
A normal DCF guesses future cash flows and works out a price. A reverse DCF runs it backwards: it starts from today's price and asks how fast free cash flow would have to grow to justify it. It tells you what the market is assuming, not whether the stock is cheap or expensive, and it is not a buy or sell signal. Glossary
Today's price implies shrinking cash flows: about -5% a year for 10 years.
Implied
-5%/yr
FCF, last 3 yrs
+12%/yr
FCF, last 5 yrs
n/a
Revenue, last 3 yrs
+0%/yr
Revenue, last 5 yrs
n/a
Same inputs as the DCF above: trailing free cash flow 0.8B, 9.9% discount rate, 2.5% growth after year 10, net debt and today's share count. Actual growth rates are compound annual rates from SEC annual filings through FY2025; "n/a" means too little history or a negative starting year.
Edit assumptions · recalculates instantly
Your value per share–
Free cash flow = operating cash flow − capital spending, trailing 12 months (TTM to 2026-06-30). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 1.14 × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.
Multiples vs sector
Forward EPS $3.43 vs trailing $4.94 (-31% expected growth). Forward P/E uses analysts' next-12-month estimate.
Backlog (remaining performance obligations)
RPO
$3.8B
as of 2026-06-30
vs a year ago
+15%
YoY
× TTM revenue
1.60×
coverage
Contracted revenue not yet recognized, from SEC filings (XBRL tag RevenueRemainingPerformanceObligation).
Quality & financial health
Gross margin
–
Operating margin
21.3%
FCF margin
33.2%
Net margin
12.3%
Return on equity
7.4%
Return on invested capital
6.0%
Net debt / EBITDA
3.5×
Current ratio
–
Interest cover
2.9×
Cash conversion (OCF/NI)
2.7×
Piotroski F-score 4/9 · last two fiscal years
✓ Positive net income✓ Positive operating cash flow✗ Return on assets improved✓ Cash flow above net income✓ Long-term debt / assets fell✗ Current ratio improved✗ No share dilution✗ Gross margin improved✗ Asset turnover improved
Altman Z-score 0.5 (distress zone; above 3.0 = safe, below 1.8 = distress). Not meaningful for banks and insurers.
Analysts
Mean target
$84
+26%
Analysts
3
Buy
Range
$79–$90
low – high
● price · ◆ mean target
Annual history
| FY | Revenue | Net income | Free cash flow |
|---|---|---|---|
| 2025 | $1.5B | $123.9M | $462.4M |
| 2024 | $1.8B | $197.7M | $396.6M |
| 2023 | $908.8M | $-551.8M | $-258.5M |
| 2022 | $1.5B | $184.5M | $325.3M |
| 2021 | $1.4B | – | $-284.0M |
From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR -0.3%.
Earnings
Next report: 2026-11-05 · during market · EPS est 0.69
EstimateActual (beat)Actual (miss)
| Report | EPS est | Actual | Surprise |
|---|---|---|---|
| 2026-08-05 | 0.99 | 2.68 | +170.1% |
| 2026-05-07 | 0.08 | 0.14 | +70.6% |
| 2026-02-19 | 0.40 | 0.10 | -75.2% |
| 2025-11-10 | 1.53 | 2.02 | +32.0% |
| 2025-08-06 | 0.84 | -0.22 | -126.1% |
| 2025-05-07 | 0.13 | 0.21 | +66.5% |
| 2025-02-26 | 2.92 | 3.25 | +11.3% |
| 2024-11-04 | 0.19 | 1.46 | +650.5% |
Quarterly revenue
| Quarter | Revenue | YoY |
|---|---|---|
| 2026-06-30 | $1.1B | +330.2% |
| 2026-03-31 | $235.9M | – |
| 2025-12-31 | $624.4M | – |
| 2025-09-30 | $390.2M | – |
| 2025-06-30 | $260.9M | – |
Analyst actions
Piper Sandler
PT $83
2026-10-12 · main
Overweight → OverweightPT $83
JP Morgan
PT $79
2026-07-16 · main
Neutral → NeutralPT $79
Piper Sandler
PT $95
2025-10-01 · main
Overweight → OverweightPT $95
JP Morgan
PT $85
2025-08-29 · main
Neutral → NeutralPT $85
JP Morgan
PT $76
2025-06-23 · down
Overweight → NeutralPT $76
Piper Sandler
PT $85
2025-05-23 · main
Overweight → OverweightPT $85
Insider trades
Grandisson Marc
$1.6M
Director, Executive Chairman, Vantage · 2026-09-23
BUY$1.6M
Davis Andrew D.
$64.5K
Chief Operating Officer, HHC · 2026-09-23
BUY$64.5K
Tighe Mary Ann
$907.6K
Director · 2026-08-11
SELL$907.6K
News
Bill Ackman Is Directing Up to $3 Billion Into Howard Hughes' Insurance Arm, Vantage, as Part of His Plan to Build a Modern Berkshire Hathaway. Is HHH Stock the Way to Play His Buffett Ambitions?
Motley Fool · Oct 16
Consumer Discretionary - Real Estate Services Q2 Earnings: Howard Hughes Holdings (NYSE:HHH) Simply the Best
StockStory · Oct 15
Howard Hughes Stock Falls 9.3% YTD: Is the Dip a Buying Opportunity?
Zacks · Oct 13
Howard Hughes Holdings Inc. Announces Dates and Times for 2026 Third Quarter Earnings Release and Conference Call
GlobeNewswire · Oct 12
Howard Hughes Holdings (HHH) Eyes A 20% Discount, Is The Stock Still Cheap?
Simply Wall St. · Oct 08
Howard Hughes Holdings Shows Huge, Unusual Out-of-the-Money Put Options Trading - Investors Bullish on HHH
Barchart · Oct 06
Cyrela Brazil Realty (CYRBY) Stock Jumps 5.8%: Will It Continue to Soar?
Zacks · Oct 05
Howard Hughes Unveils Insurance-Led Strategy After Board Wins Strong Support
MarketBeat · Oct 04
Vantage Announces Appointment of Lucy Fato as General Counsel
PR Newswire · Aug 20
Stats refreshed 2026-10-19 19:01:46 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now
coteau
Coteau Systematic StrategiesSystematic equity research and model portfolios.Coteau Systematic Strategies publishes research, model portfolios and tools. It does not manage money or offer investment advice. Model results are hypothetical. Data: Yahoo Finance (delayed), SEC EDGAR.